Prevention of mental health disorders (depression, anxiety) and increased uptake of HIV prevention and treatment services Mental and Behavioural Disorders
Conditions
Interventions
After recruitment, from separate listings of MSM and transgender women (TGW) enrolled participants, an investigator used a random numbers table and assigned individuals from each list to an interventi
there were separate groups for MSM or TGW (given different experiences and social networks). Within 10 days of completion of the baseline survey, research assistants called participants to inform them
Sponsors
Population Council
Eligibility
Sex/Gender
Male
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: 1. 18 years or older 2. Assigned male at birth 3. [Among MSM subgroup] Had sex with a biological man in the last year; [Among Transgender women subgroup] Identify as a woman 4. Willing to participate in all four sessions of the intervention 5. Willing to participate in the study 6. Residing in Lagos State for the next 1 year
Exclusion criteria
Exclusion criteria: 1. Do not agree to participate in either the group sessions or study surveys 2. Planning to move out of Lagos State within the next one year 3. Currently participating in any other stigma reduction intervention 4. Not providing consent to participate in the intervention and study 5. Not providing contact information for follow-up
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Internalized stigma related to being a sexual/gender minority and living with HIV (among those individuals living with HIV), measured using an adaptation of the Internalized AIDS-Related Stigma Scale (IA-RSS) at baseline and three additional points (approximately 1 month after baseline, 2 months after baseline, and 3 months after baseline) | — |
Secondary
| Measure | Time frame |
|---|---|
| Measured at baseline and three additional points (approximately 1 month after baseline, 2 months after baseline, and 3 months after baseline): 1. Depression measured using the Patient Health Questionnaire-8 (PHQ-8) 2. Anxiety measured using the General Anxiety Disorder-7 (GAD-7), such as ‘trouble relaxing’ and ‘not being able to control or stop worrying’ in the last 2 weeks 3. Coping was measured using the 4-item Brief Coping Scale 4. Uptake of pre-exposure prophylaxis and antiretroviral therapy (among participants living with HIV). Among those with HIV, adherence was defined as reporting “No days” to the question “During the past 3 days, on how many days have you missed all your pills?”. Antiretroviral treatment self-efficacy was assessed based on seven items from a validated scale (HIV-Adherence Self-Efficacy Scale with last month as the reference period. | — |
Countries
Nigeria
Contacts
Public ContactWaimar Tun
Outcome results
None listed